The firm developed a smart spirometer that can accurately measure lung function (FEV1, FVC, FEV1/FVC, FEFmax), transfer that information to a smartphone and onto the physician. The MySpirometer is not yet available on the market, but the firm has already completed waveform testing with the American Thoracic Society and European Respiratory Society and is starting to move the product toward commercialization. The device is designed to be very easy to use, by both adults and children, whi...